Introduction
the characteristics of a true malignancy. In 1872, a Viennese dermatologist, Moritz Kaposi, reported three adult males with multiple hyperpig-Epidemiology of KS after renal transplantation mented cutaneous nodules on their legs which he termed 'idiopathic multiple pigmented sarcoma of the The prevalence of KS after renal transplantation varies skin' [1] . This disease originally was considered to be greatly depending on geography. Table 1 summarizes a rare neoplasm with a protracted clinical course that the main data from the literature [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . In many affected older individuals. It is now eponymously desigcountries, where the prevalence of KS in allograft nated Kaposi's sarcoma ( KS) although it is no longer recipients is low, most transplant recipients with KS considered neoplastic by many authors [2] . Kaposi come from abroad. Post-transplantation KS affects described the sporadic or classic subtype. Other differmainly patients originating from Mediterranean, black ent main subtypes subsequently have been described:
African or Caribbean countries. The same populations the endemic subtype observed in black Africans; the are also affected by sporadic or endemic KS. The epidemic subtype in patients infected with human magnitude of the increase of risk of KS conferred by immunodeficiency virus (HIV ); and the iatrogenic transplantation was evaluated in several studies. It subtype in patients treated with immunosuppressive ranged from 25-to 400-fold in Toronto between 1979 therapy, especially organ transplant recipients.
and 1997 [7, 19] No genetic predisposition to KS has been identified legs, they may also appear on the trunk and the arms.
Involvement of the face is less frequent than in epito date; the predominance of HLA-DR5-initially found in sporadic KS-is no longer considered univer-demic KS. Kö bner's phenomenon, i.e. the appearance of the lesions in scars, occasionally is noted. This sally valid, and this includes KS after organ transplantation [20] . The male predominance-well-known concerns especially the scar resulting from transplantation surgery (Figure 2 ). Leg oedema often pre-dates in sporadic, endemic and epidemic KS-is also found in KS of transplant recipients, the male/female ratio skin lesions on the legs by months. KS is difficult to diagnose in the initially oedematous stage when skin varying from 2 to 40 in different studies [7, 9] . The patient's age at onset of KS depends essentially on the lesions are absent. In this situation, serological tests for human herpes virus-8 (HHV-8) may be useful to age at the time of organ transplantation:~40 years in most cases. However, paediatric cases have been make an early diagnosis of KS. Oral lesions consist predominantly of purple stains on the palate reported [21] . The average interval between organ transplantation and the onset of KS is 20 months, ( Figure 3 ). Gingival hyperplasia may occur and has to be differentiated from hyperplasia induced by cyclosporanging from a few weeks to 18 years. This average time interval is less,~12 months, in recipients treated rin. As in epidemic KS, oral lesions frequently are associated with involvement of the gastrointestinal with cyclosporin A [22] .
tract. Involvement of genital mucosa or conjunctiva is less frequent. Usually these dermatological lesions
Clinical and pathological features
cause moderate aesthetic or functional discomfort. Superinfection may occur when lesions are ulcerated. Extracutaneous KS most frequently involves the Skin lesions are seen in >90% of all cases with KS.
lymph nodes, the gastrointestinal tract and the lungs. Lesions have a dark blue or purplish colour on white Enlarged lymph nodes should be biopsied to exclude skin ( Figure 1 ) and often appear pigmented on black the possibility of associated lymphoma which is found skin ( Figure 2 ). Initially, they may be macular and in 2% of cases according to Penn's series of 356 patients may coalesce to form large plaques. They subsequently [23] . Although lesions of KS can be found throughout are infiltrated and may form nodular and fungiform the entire gastrointestinal tract, the most common tumours. Although they are localized mainly on the localizations are stomach and duodenum. The lesions rarely cause clinical symptoms, e.g. nausea, major bleeding, perforation or obstruction, but usually are detected as more or less infiltrated red spots during endoscopic examination of asymptomatic patients.
Pulmonary involvement appears at a more advanced stage of the disease; it may cause dyspnea, hypoxaemia and hypocapnia with diffuse interstitial infiltrates, pulmonary nodules and/or pleural infusions. Many other localizations have been reported, especially hepatosplenic involvement.
Regardless of the localization, the diagnosis of KS can be confirmed on the basis of its histological features. Early patch-like lesions exhibit only irregular capillaries sprouting out from normal capillaries. As the lesions develop, a network of spindle-shaped cells is seen as well as large vascular spaces surrounded by an endothelial cell layer. The predominant features of the tumour stage are interweaving bands of spindle cells embedded in a reticulin network; these lesions consistently are associated with the vascular spaces above. Extravasated erythrocytes may be seen. Around the cellular clusters, hemosiderin-laden macrophages are found as well as a moderate inflammatory infiltrate.
Staging
The disease is usually classified according to the fourstage classification described by Al-Khader et al. in 1988 [24] . Stage 1: localized skin lesions involving only one limb. Stage 2: involvement of the skin only, but widespread skin lesions involving more than one limb. This classification is simple and widely used. It indicates the extension of KS, but does not take into account information which is essential for therapeutic decisions, e.g. functional disability, rate of development of KS lesions and vital risk.
Human herpes virus 8 (HHV-8) infection and co-infection with other microorganisms
HHV-8 has been detected in AIDS-associated KS [25] and is now clearly associated with all epidemiological forms of KS. HHV-8 may be sexually transmitted [26 ] . Other possibilities of transmission of HHV-8 remain unknown. HHV-8 sequences have been detected in almost all KS tissue samples irrespective of the subtype of KS. They may also be found in mononuclear cells of peripheral blood. Whether quantitation of HHV-8 DNA in blood cells or tissues provides clinically useful information is unknown and will have to be evaluated in prospective studies. Epidemiological data suggest that a high prevalence of anti-HHV-8 antibodies in the general population is correlated with a higher frequency of KS after renal transplantation. Seroprevalence is very high in some African countries (>50%), moderate in Italy and lower in other Western countries [27] . Most transplant recipients have anti-HHV-8 antibodies in their sera before immunosuppression is started, suggesting that subsequent KS results from reactivation of the virus [28] . Potential transmission of HHV-8 from the donor allograft to the recipient has been documented recently in one case [28] . Such transmission could explain rare, but intriguing, cases where KS appeared simultaneously in two recipients receiving allografts from the same donor [29] . If this possibility is substantiated by further observations, underway in some patients at the time when their KS every donor will have to undergo anti-HHV-8 serolo-lesions were treated. Lesions may regress in a few gical testing in the future. HHV-8 encodes genes [30, 31] weeks after immunosuppression has been tapered. In that may cause KS via stimulating angiogenesis, e.g. our experience, however, regression is often slower and through cytokine homologues such as interleukin-6, can take several months. Regression can be monitored G-protein receptor, etc.
by assessing the size of mucocutaneous lesions. Whilst Viral, bacterial, fungal or parasitic infections are the development of cutaneous and visceral lesions does probably a factor aggravating KS and should, there-not occur consistently in parallel, they usually regress fore, be treated promptly. They have been reported in simultaneously. Regression of KS lesions is not an aim many anecdotal observations, but controlled pros-to be pursued at any price. For instance, some patients pective information on their prevalence in post-prefer maintaining good graft function, even if this transplantation KS is not available [32] .
means that a few skin lesions of KS persist. Very specific therapies are available when lesions of KS (i) spread, (ii) cause functional or aesthetic discomTreatment fort or (iii) pose life-threatening risks. Cryotherapy, cryosurgery, laser or surgical removal yield aestheticTreatment of KS in renal transplant recipients varies ally acceptable results and can be recommended when greatly between different institutions, and this makes a limited number of cutaneous or mucosal lesions are analysis of the data reported in the literature difficult. present. Intralesional chemotherapy has also been There is consensus that immunosuppressive drugs must recommended, but it is less popular because it is be tapered to the lowest level which is consistent with painful. Lesions regress more rapidly after radioallograft function. The degree to which immuno-therapy, but this modality poses the long-term risk suppressive drugs can be reduced depends on the rate of cutaneous carcinomas. Various chemotherapeutic of development of the lesions, functional disability and agents, singly or in combination, have been proposed. vital risk posed by KS. Associated infections must be None has proven to be superior. The most commonly treated whenever feasible: we observed one patient used chemotherapeutic agents for monotherapy are with extensive cutaneous KS which disappeared withvinblastine (0.1 mg/kg/week for 5-10 weeks) and bleoout any modification of the immunosuppressive regimycin (7.5 mg/week or 15 mg every 2 weeks). When men once tuberculosis have been treated. In many multivisceral involvement progresses rapidly, many cases, lowering the dose of immunosuppressive drugs authors advise combination of chemotherapy, e.g. adrimay be sufficient to cause disappearance of the KS amycin or doxorubicin, bleomycin, and vinblastine lesions. In the Cincinnati registry, KS disappeared or vincristine (ABV ), or etoposide and cisplastin. after immunosuppression had been reduced in 17% of Combination chemotherapy is able to control KS, but 213 patients with mucocutaneous involvement and 16% at the price of increasing immunosuppression. KS may of 143 patients with single or multiple visceral involverecur several months or years after remission [7] . ment [23] . These figures presumably are underestimated, since regression of lesions was already Interferon-a is used widely in endemic KS. After renal 8. Webb MC, Compton F, Andrews PA, Koffman CG. Skin transplantation, it cannot be recommended because it tumours posttransplantation. A retrospective analysis of 28 often triggers rejection [33] .
years' experience at a single center. 
